1 / 7

Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis. ALS: What is It?. Neurodegenerative Affects CNS Affects Motor Pathways Types: Sporadic and Familial Onset: 40-70 years of age Prognosis: 80% will die within 3-5 years of onset. Symptoms.

denna
Télécharger la présentation

Amyotrophic Lateral Sclerosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Amyotrophic Lateral Sclerosis

  2. ALS: What is It? • Neurodegenerative • Affects CNS • Affects Motor Pathways • Types: Sporadic and Familial • Onset: 40-70 years of age • Prognosis: 80% will die within 3-5 years of onset

  3. Symptoms • Muscle fatigue and weakness in limbs, hands, and muscles of speaking and breathing • Manifestations in tripping, slurred speech, quiet voice projection, difficulty in everyday motor tasks using fine detail or expending muscle energy • Later in the Disease progression: partial or full paralysis, inability to speak or breath

  4. Biology: Cell Level • Mitochondria: influx of SOD1 triggering apoptosis • Glutamate: secretion of too much glutamate leads to toxic over-excitation of postsynaptic neuron • Genetics- in as many a 15% of cases scientists have found a specific gene mutation causing RNA to make proteins clump • Inflammation: damaged cells attract TNF alpha messengers from the immune system • Axons: protein malfunction in axons affect structure and shuttling of molecules up and down its length

  5. Biology • IGF and GH: imbalance of growth hormones found in ALS patients. • Apoptosis: cell suicide and cell death much higher in ALS patients due to damages cells • Grey Matter: reduced volume of grey matter especially in front and temporal lobes and precentral gyrus

  6. Treatment • Riluzole: glutamate moderation presynaptically and postsynaptically

  7. Future Treatments • Gene therapy: targets SOD1 • RNA therapy: matched RNA to prevent production of bad protein • Current Drugs: insulin therapy and antibiotic therapy for glutamate • Stem cell therapy: replace damaged cells

More Related